These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8824243)

  • 1. Reduction of dopamine beta-monooxygenase. A unified model for apparent negative cooperativity and fumarate activation.
    Wimalasena K; Dharmasena S; Wimalasena DS; Hughbanks-Wheaton DK
    J Biol Chem; 1996 Oct; 271(42):26032-43. PubMed ID: 8824243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperativity in the dopamine beta-monooxygenase reaction. Evidence for ascorbate regulation of enzyme activity.
    Stewart LC; Klinman JP
    J Biol Chem; 1991 Jun; 266(18):11537-43. PubMed ID: 2050664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.
    Wimalasena DS; Jayatillake SP; Haines DC; Wimalasena K
    Biochem J; 2002 Oct; 367(Pt 1):77-85. PubMed ID: 12038965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A slow-tight binding inhibitor of dopamine beta-monooxygenase: a transition state analogue for the product release step.
    Dharmasena SP; Wimalasena DS; Wimalasena K
    Biochemistry; 2002 Oct; 41(41):12414-20. PubMed ID: 12369831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral multisubstrate inhibitors of dopamine beta-monooxygenase: evidence for dual modes of interaction.
    Wimalasena K; Wimalasena DS; Dharmasena S; Haines DC; Alliston KR
    Biochemistry; 1997 Jun; 36(23):7144-53. PubMed ID: 9188714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that dioxygen and substrate activation are tightly coupled in dopamine beta-monooxygenase. Implications for the reactive oxygen species.
    Evans JP; Ahn K; Klinman JP
    J Biol Chem; 2003 Dec; 278(50):49691-8. PubMed ID: 12966104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of modulation of dopamine beta-monooxygenase by pH and fumarate as deduced from initial rate and primary deuterium isotope effect studies.
    Ahn N; Klinman JP
    Biochemistry; 1983 Jun; 22(13):3096-106. PubMed ID: 6882739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic evidence for channeling of dopamine between monoamine transporter and membranous dopamine-beta-monooxygenase in chromaffin granule ghosts.
    Wimalasena DS; Wimalasena K
    J Biol Chem; 2004 Apr; 279(15):15298-304. PubMed ID: 14732710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous spectrophotometric assays for dopamine beta-monooxygenase based on two novel electron donors: N,N-dimethyl-1,4-phenylenediamine and 2-aminoascorbic acid.
    Wimalasena K; Wimalasena DS
    Anal Biochem; 1991 Sep; 197(2):353-61. PubMed ID: 1785690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of dopamine beta-monooxygenase by external and internal electron donors in resealed chromaffin granule ghosts.
    Ahn NG; Klinman JP
    J Biol Chem; 1987 Feb; 262(4):1485-92. PubMed ID: 3805036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alternate reductant binding and electron transfer in the dopamine beta-monooxygenase reaction.
    Stewart LC; Klinman JP
    Biochemistry; 1987 Aug; 26(17):5302-9. PubMed ID: 3676254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic characterization of rat serum dopamine-beta-hydroxylase using a simplified radioenzymatic assay.
    Henry DP; Johnson DG; Starman BJ; Williams RH
    Life Sci; 1975 Oct; 17(7):1179-86. PubMed ID: 573
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional role of fumarate site Glu59 involved in allosteric regulation and subunit-subunit interaction of human mitochondrial NAD(P)+-dependent malic enzyme.
    Hsieh JY; Chiang YH; Chang KY; Hung HC
    FEBS J; 2009 Feb; 276(4):983-94. PubMed ID: 19141113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion activation of dopamine beta-hydroxylase: a kinetic model.
    Palatini P
    Int J Biochem; 1988; 20(4):427-33. PubMed ID: 3366300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduction of membrane-bound dopamine beta-monooxygenase in resealed chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents?
    Wimalasena K; Wimalasena DS
    J Biol Chem; 1995 Nov; 270(46):27516-24. PubMed ID: 7499210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of intrinsic isotope effects in the dopamine beta-monooxygenase reaction.
    Miller SM; Klinman JP
    Biochemistry; 1983 Jun; 22(13):3091-6. PubMed ID: 6882738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis.
    Li C; Oldham CD; May SW
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):31-6. PubMed ID: 8198547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of ascorbate oxidase: unexpected similarity to the reduction site of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1471-6. PubMed ID: 7945293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.